Controversies around the function of LARP1Andrea J. Berman, Sarah P. Blagden, Carson C. Thoreen et al.|RNA Biology|2020Cited by 99
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms <i>In Vitro</i> and in a First-In-Human Phase I Clinical TrialHagen Schwenzer, Sarah P. Blagden, Erica De Zan et al.|Clinical Cancer Research|2021Cited by 44
LARP1 isoform expression in human cancer cell linesHagen Schwenzer, Sarah P. Blagden, Josephine Morris et al.|RNA Biology|2020Cited by 18
Ancient and modern: hints of a core post‐transcriptional network driving chemotherapy resistance in ovarian cancerSarah P. Blagden, James Chettle, Mai Abdel Mouti|Wiley Interdisciplinary Reviews - RNA|2017Cited by 13
LARP1 haploinsufficiency is associated with an autosomal dominant neurodevelopmental disorderJames Chettle, Sarah P. Blagden, Raymond J. Louie et al.|Human Genetics and Genomics Advances|2024Cited by 5